Neu auf wallstreet:online?
Jetzt registrieren | Login
x
Benutzername:

Passwort:

Angemeldet bleiben
Passwort vergessen?

EANS-Adhoc LifeWatch contracts with an additional 41 Payors for ACT and Home Sleep Testing in Q1 2012 (with document)

Nachrichtenagentur: news aktuell
 |  02.05.2012, 18:11  |  259 Aufrufe  |   | 
--------------------------------------------------------------------------------
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide
distribution. The issuer is solely responsible for the content of this
announcement.

--------------------------------------------------------------------------------

Contracts/LifeWatch AG

02.05.2012

Neuhausen am Rheinfall / Switzerland - LifeWatch AG (SIX Swiss
Exchange: LIFE), the leading wireless remote cardiac and medical
patient monitoring service provider in the U.S., announced today that
it has contracted with 20 new providers for its ACT Ambulatory
Cardiac Telemetry services and a further 21 new providers for its
Home Sleep testing services during the first quarter of 2012.
Collectively, the new agreements represent over 71 million covered
lives.

You will find a PDF-version of this press release at the end of this
message.

LifeWatch continues its vigorous pursuit to increase its portfolio of
contracted payors across the nation for all of its service lines. Of
notable mention are the following contracts completed in Q1 2012:

+ United HealthCare (UHC) and all of its affiliates:

Completed a major new follow-on national agreement as an In-Network
Preferred Provider providing coverage of our standard cardiac event
monitoring and home sleep testing services to approximately 70
million members. Specifically and importantly this contract added the
availability of LifeWatch's NiteWatch home sleep test to the UHC
nationwide network of 595,000 physicians and other health care
professionals. LifeWatch is also the sole In-Network provider for
UHC's Medicare members for ambulatory cardiac telemetry (ACT).

+ Prime/NAMM:

Contracted for cardiac monitoring services including ACT to their
205,000 members. NAMM develops and manages provider networks in
California, with a client network of over 600 primary care
physicians, 1,200 specialists and premier hospitals.

+ Dimension Health PPO:

Contracted with South Florida's largest Preferred Provider
Organization(PPO) Network for Home Sleep Test services for covering
approximately 400,000 lives. Dimension Health is a high quality, cost
effective, community based network that insurers, employers, unions
and government sponsored health programs provide to their employees.

+ Fidelis Care of NY:

Contracted for all LifeWatch service lines to provide coverage to its
more than 725,000 Managed Medicaid and dual-eligible Medicare
enrollees in 58 counties, making them the largest government
programs-based health insurance company in New York State.

"LifeWatch continues to prove to providers the value of our cost
effective health monitoring services, " stated Dr. Yacov Geva,
Chairman and CEO of LifeWatch AG, which is the parent company of
LifeWatch Services, Inc. "These new contracts corroborate our
momentum in obtaining important coverage and payment contracts and
that the market is starting to shift from Sleep Labs to the more cost
effective non-attended home sleep testing".

About LifeWatch AG:

LifeWatch AG, headquartered in Neuhausen am Rheinfall and listed on
SIX Swiss Exchange (LIFE), Switzerland, is the leading healthcare
technology and solution company, specializing in advanced telehealth
systems and wireless remote patient monitoring services. LifeWatch
services cater to individuals, ranging from high-risk and chronically
ill patients, to consumers of health and wellness products. LifeWatch
has subsidiaries in the United States, the Netherlands, Japan, the
United Kingdom, Switzerland and Israel. LifeWatch AG is the parent
company of LifeWatch Services Inc., a leading US-based cardiac
monitoring service provider, and manufacturer of telecardiology
products. LifeWatch is also introducing a new program for Home Sleep
Testing of Obstructive Sleep Apnea (OSA) patients under the brand
name NiteWatch. For additional information, please visit
www.lifewatch.com.

Sign-up for customized E-mail alerts and documentation requests is
available at http://production.investis.com/lifewatch/alert-service/

This press release includes forward-looking statements. All
statements other than statements of historical facts contained in
this press release, including statements regarding future results of
operations and financial position, business strategy and plans and
objectives for future operations, are forward-looking statements. The
words "believe, " "may, " "will, " "estimate, " "continue, ""anticipate, "
"intend, " "expect" and similar expressions are intended to identify
forward-looking statements. LifeWatch AG has based these
forward-looking statements largely on current expectations and
projections about future events and financial trends that it believes
may affect the financial condition, results of operations, business
strategy, short term and long-term business operations and
objectives, and financial needs. These forward-looking statements are
subject to a number of risks, uncertainties and assumptions. In light
of these risks, uncertainties and assumptions, the forward-looking
events and circumstances described may not occur and actual results
could differ materially and adversely from those anticipated or
implied in the forward-looking statements. All forward-looking
statements are based only on data available to LifeWatch AG at the
time of the issue of this press release. LifeWatch AG does not
undertake any obligation to update any forward-looking statements
contained in this press release as a result of enw information,
future events or otherwise.

THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF
AMERICA AND SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR
PUBLICATIONS WITH A GENERAL CIRCULATION IN THE UNITED STATES. THIS
PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH
AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED STATES OR AN
INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF LIFEWATCH
AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE
SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN
REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE
OFFERED, SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO U.S.
PERSONS ABSENT REGISTRATION UNDER OR AN APPLICABLE EXEMPTION FROM THE
REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES LAWS. ANY
PUBLIC OFFERING OF SECURITIES TO BE MADE IN THE UNITED STATES WILL BE
MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM LIFEWATCH AG
OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED
INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL
STATEMENTS OF THE ISSUER.

Attachments with Announcement:
----------------------------------------------
http://resources.euroadhoc.com/us/LZrurKZz

Further inquiry note:
Sensus Investor and Public Relations GmbH, Zürich:

Tel +41 43 366 55 11 | Fax +41 43 366 55 12 | Email lifewatch@sensus.ch

end of announcement euro adhoc
--------------------------------------------------------------------------------

Attachments with Announcement:

----------------------------------------------

http://resources.euroadhoc.com/us/LZrurKZz

issuer: LifeWatch AG
Rundbuckstrasse 6
CH-8212 Neuhausen am Rheinfall
phone: +41 52 632 00 50
FAX: +41 52 632 00 51
mail: users@lifewatch.com
WWW: www.lifewatch.com
sector: Healthcare Providers
ISIN: CH0012815459
indexes: SPI, SPIEX
stockmarkets: free trade: Berlin, Open Market / XETRA: Frankfurt, Main Standard:
SIX Swiss Exchange
language: English

Schreibe Deinen Kommentar

 

Disclaimer

Nachrichtenagentur

Weitere Nachrichten des Autors

TitelLeser
104
99
93
93
84
82
72
72
69
65
TitelLeser
360
348
340
332
317
307
292
275
273
268
TitelLeser
895
877
804
707
693
665
631
559
484
360
TitelLeser
10143
6299
6244
5429
5269
3661
3578
3380
3038
2517